Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China.
Comput Math Methods Med. 2022 Aug 4;2022:9111681. doi: 10.1155/2022/9111681. eCollection 2022.
Lung cancer is the cancer with the highest morbidity and mortality. Lung adenocarcinoma (LUAD) is a subtype of lung cancer. The aim of this study is to explore the functions of miR-579 and CRABP2 in lung adenocarcinoma.
Cell counting kit-8 (CCK-8) and colony formation assays were applied to calculate cell proliferative abilities. Transwell assay was utilized to measure cell invasive ability.
MiR-579 is low expressed in LUAD tissues and cell lines. MiR-579 inhibits cell viability and invasion of lung adenocarcinoma. Knockdown of CRABP2 inhibits cell proliferation and invasion of Calu-3 cells. MiR-579 suppresses cell proliferation and invasion by regulating CRABP2 in Calu-3 cells.
Our study reveals that miR-579 acts as a tumor suppressor in LUAD and miR-579 can target and regulate the expression of CRABP2 to mediate cell proliferation and invasion. This study indicates that miR-579 has a potential to be a candidate biomarker for the treatment of LUAD.
肺癌是发病率和死亡率最高的癌症。肺腺癌(LUAD)是肺癌的一种亚型。本研究旨在探讨 miR-579 和 CRABP2 在肺腺癌中的作用。
用细胞计数试剂盒-8(CCK-8)和集落形成实验来计算细胞增殖能力。Transwell 实验用于测量细胞侵袭能力。
miR-579 在 LUAD 组织和细胞系中低表达。miR-579 抑制肺腺癌细胞活力和侵袭。CRABP2 的敲低抑制 Calu-3 细胞的增殖和侵袭。miR-579 通过在 Calu-3 细胞中调节 CRABP2 来抑制细胞增殖和侵袭。
本研究表明,miR-579 在 LUAD 中作为一种肿瘤抑制因子发挥作用,miR-579 可以靶向并调节 CRABP2 的表达,从而调节细胞增殖和侵袭。这项研究表明,miR-579 有潜力成为 LUAD 治疗的候选生物标志物。